DYADIC INTERNATIONAL INC Income (Loss) Attributable to Parent, before Tax
DYADIC INTERNATIONAL INC (DYAI) reported Income (Loss) Attributable to Parent, before Tax of -$7.36 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossAttributableToParent · last filed 2026-03-25
- DYADIC INTERNATIONAL INC income (loss) attributable to parent, before tax for the quarter ending 2020-12-31 was -$1.93M.
- DYADIC INTERNATIONAL INC income (loss) attributable to parent, before tax for the quarter ending 2020-09-30 was -$2.50M.
- DYADIC INTERNATIONAL INC income (loss) attributable to parent, before tax for the quarter ending 2020-06-30 was -$2.65M.
- DYADIC INTERNATIONAL INC income (loss) attributable to parent, before tax for the quarter ending 2020-03-31 was -$2.21M.
- DYADIC INTERNATIONAL INC income (loss) attributable to parent, before tax for fiscal 2025 was -$7.36M.
- DYADIC INTERNATIONAL INC income (loss) attributable to parent, before tax for fiscal 2024 was -$5.81M.
- DYADIC INTERNATIONAL INC income (loss) attributable to parent, before tax for fiscal 2023 was -$6.80M.
- DYADIC INTERNATIONAL INC income (loss) attributable to parent, before tax for fiscal 2022 was -$9.74M.
| Period end | Income (Loss) Attributable to Parent, before Tax 3 month | Income (Loss) Attributable to Parent, before Tax 6 month | Income (Loss) Attributable to Parent, before Tax 9 month | Income (Loss) Attributable to Parent, before Tax 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$7.36M 10-K · filed 2026-03-25 | |||
| 2024-12-31 | -$5.81M 10-K · filed 2026-03-25 | |||
| 2023-12-31 | -$6.80M 10-K · filed 2025-03-26 | |||
| 2022-12-31 | -$9.74M 10-K · filed 2024-03-28 | |||
| 2021-12-31 | -$13.07M 10-K · filed 2023-03-29 | |||
| 2020-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$4.43M derived: sum of 2 quarters · filed 2022-03-29 | -$7.08M derived: sum of 3 quarters · filed 2022-03-29 | -$9.29M 10-K · filed 2022-03-29 |
| 2020-09-30 | -$2.50M 10-Q · filed 2020-11-12 | -$5.15M derived: sum of 2 quarters · filed 2020-11-12 | -$7.37M 10-Q · filed 2020-11-12 | -$9.09M derived: sum of 4 quarters · filed 2021-03-30 |
| 2020-06-30 | -$2.65M 10-Q · filed 2020-08-13 | -$4.87M 10-Q · filed 2020-08-13 | -$6.59M derived: sum of 3 quarters · filed 2021-03-30 | -$8.29M derived: sum of 4 quarters · filed 2021-03-30 |
| 2020-03-31 | -$2.21M 10-Q · filed 2020-05-14 | -$3.94M derived: sum of 2 quarters · filed 2021-03-30 | -$5.64M derived: sum of 3 quarters · filed 2021-03-30 | -$8.34M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-12-31 | -$1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | -$3.43M derived: sum of 2 quarters · filed 2021-03-30 | -$6.12M derived: sum of 3 quarters · filed 2021-03-30 | -$8.30M 10-K · filed 2021-03-30 |
| 2019-09-30 | -$1.70M 10-Q · filed 2020-11-12 | -$4.39M derived: sum of 2 quarters · filed 2020-11-12 | -$6.57M 10-Q · filed 2020-11-12 | -$8.09M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$2.70M 10-Q · filed 2020-08-13 | -$4.87M 10-Q · filed 2020-08-13 | -$6.39M derived: sum of 3 quarters · filed 2020-08-13 | -$7.93M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | -$2.17M 10-Q · filed 2020-05-14 | -$3.69M derived: sum of 2 quarters · filed 2020-05-14 | -$5.23M derived: sum of 3 quarters · filed 2020-05-14 | -$6.83M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$1.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$3.06M derived: sum of 2 quarters · filed 2020-03-30 | -$4.65M derived: sum of 3 quarters · filed 2020-03-30 | -$6.70M 10-K · filed 2020-03-30 |
| 2018-09-30 | -$1.54M 10-Q · filed 2019-11-13 | -$3.14M derived: sum of 2 quarters · filed 2019-11-13 | -$5.18M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$1.60M 10-Q · filed 2019-08-13 | -$3.64M 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | -$2.04M 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | -$2.20M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |